Literature DB >> 29282375

Can innate immune system targets turn up the heat on 'cold' tumours?

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29282375     DOI： 10.1038/nrd.2017.264

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  15 in total

1.  PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.

Authors:  Roman M Chabanon; Gareth Muirhead; Dragomir B Krastev; Julien Adam; Daphné Morel; Marlène Garrido; Andrew Lamb; Clémence Hénon; Nicolas Dorvault; Mathieu Rouanne; Rebecca Marlow; Ilirjana Bajrami; Marta Llorca Cardeñosa; Asha Konde; Benjamin Besse; Alan Ashworth; Stephen J Pettitt; Syed Haider; Aurélien Marabelle; Andrew Nj Tutt; Jean-Charles Soria; Christopher J Lord; Sophie Postel-Vinay
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

2.  Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.

Authors:  Yuta Yanase; Genichiro Tsuji; Miki Nakamura; Norihito Shibata; Yosuke Demizu
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.

Authors:  Mohamed Wehbe; Lihong Wang-Bishop; Kyle W Becker; Daniel Shae; Jessalyn J Baljon; Xinyi He; Plamen Christov; Kelli L Boyd; Justin M Balko; John T Wilson
Journal:  J Control Release       Date:  2020-11-12       Impact factor: 9.776

Review 4.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

5.  Extracellular vesicles derived from ODN-stimulated macrophages transfer and activate Cdc42 in recipient cells and thereby increase cellular permissiveness to EV uptake.

Authors:  Ying Zhang; Xue Jin; Jiaqi Liang; Yilan Guo; Gaoge Sun; Xianfeng Zeng; Hang Yin
Journal:  Sci Adv       Date:  2019-07-24       Impact factor: 14.136

Review 6.  Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.

Authors:  Lisa Haas; Anna C Obenauf
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

Review 7.  STING modulators: Predictive significance in drug discovery.

Authors:  Xiangling Cui; Rongyu Zhang; Shan Cen; Jinming Zhou
Journal:  Eur J Med Chem       Date:  2019-08-08       Impact factor: 6.514

8.  Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.

Authors:  Lihong Wang-Bishop; Mohamed Wehbe; Daniel Shae; Jamaal James; Benjamin C Hacker; Kyle Garland; Plamen P Chistov; Marjan Rafat; Justin M Balko; John T Wilson
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

Review 9.  Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?

Authors:  Klaus-Peter Künkele; Daniela Wesch; Hans-Heinrich Oberg; Martin Aichinger; Verena Supper; Christoph Baumann
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

10.  Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.

Authors:  Daniel Shae; Kyle W Becker; Plamen Christov; Dong Soo Yun; Abigail K R Lytton-Jean; Sema Sevimli; Manuel Ascano; Mark Kelley; Douglas B Johnson; Justin M Balko; John T Wilson
Journal:  Nat Nanotechnol       Date:  2019-01-21       Impact factor: 39.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.